Catheter Precision to present data on its FDA-cleared VIVO 3D imaging tool at the 19th annual International Ventricular Tachycardia Symposium.

Catheter Precision, Inc. will attend the 19th annual International Ventricular Tachycardia Symposium on October 11-12 in New York City. The event will cover management strategies for ventricular arrhythmias. The company plans to present data on its VIVO™ system, a non-invasive 3D imaging tool that aids in identifying arrhythmia origins before procedures. VIVO has received FDA marketing clearance and CE marking.

October 10, 2024
5 Articles

Further Reading